Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients

AIMS: Vedolizumab (VDZ) prevents migration of activated leucocytes into inflamed mucosa. This study aimed to assess the patterns of serum cytokines in ulcerative colitis (UC) patients at baseline and during VDZ treatment, and to investigate their association with mucosal healing and clinical remissi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Clin Pharmacol
Huvudupphovsmän: Bertani, Lorenzo, Baglietto, Laura, Antonioli, Luca, Fornai, Matteo, Tapete, Gherardo, Albano, Eleonora, Ceccarelli, Linda, Mumolo, Maria Gloria, Pellegrini, Carolina, Lucenteforte, Ersilia, de Bortoli, Nicola, Bellini, Massimo, Marchi, Santino, Blandizzi, Corrado, Costa, Francesco
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319004/
https://ncbi.nlm.nih.gov/pubmed/32027388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14235
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk